Ask Warren

Samsung Pharmaceutical

001360 · KOSPI · ₩001360 · 삼성제약

₩1,251▼ ₩3 (0.24%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩46B₩44B₩52B₩52B₩55B
Cost of sales₩32B₩25B₩29B₩27B₩46B
Gross profit₩14B₩20B₩23B₩25B₩9.3B
Operating income−₩18B−₩15B−₩18B−₩14B−₩18B
Net income₩12B−₩14B−₩25B−₩25B−₩40B
Net income to shareholders₩12B−₩14B−₩25B−₩25B−₩40B

Balance sheet

20252024202320222021
Total assets₩167B₩128B₩93B₩118B₩145B
Current assets₩39B₩47B₩29B₩70B₩85B
Cash and equivalents₩11B₩7.4B₩4.3B₩36B₩26B
Total liabilities₩46B₩23B₩16B₩15B₩18B
Current liabilities₩42B₩19B₩13B₩14B₩17B
Borrowings₩17B₩4B₩0₩313M₩266M
Total equity₩121B₩106B₩78B₩103B₩127B
Shareholders' equity₩121B₩106B₩78B₩103B₩127B

Cash flow

20252024202320222021
Cash from operations−₩10B−₩17B−₩28B−₩1.9B−₩7.2B
Capital spending₩54M₩329M₩774M₩2B₩3.6B
Free cash flow−₩10B−₩18B−₩28B−₩4B−₩11B

Consolidated where available. Amounts in won.

Also known as: Samsung Pharmaceutical / 삼성제약 / 001360 / KRX:001360

Source: KRX statistical information